Friday, November 8, 2024
HomeFunding Aplantex Secures CAD$2.8 Million Financing to Accelerate its Development

[Funding News] Aplantex Secures CAD$2.8 Million Financing to Accelerate its Development

Canada-based Aplantex, innovative Quebec-based startup specializing in extracting high-value plant molecules from its proprietary biomass, has secured $2.8 million CAD Financing led by Frederick Perrault, with participation of the Circular Innovation Fund (CIF) through its Acceleration Program, Cycle Momentum, Investissement Québec, and a number of angel investors. This funding will accelerate the development of the company’s strategic and production plan.

Read also – [Funding News] Pryzm Secures Oversubscribed $2 Milion in Funding

The Aplantex scientific team has developed a unique process for producing certified molecules of commercial interest with high added value. The heart of this green biotechnology process for efficient and sustainable phytochemistry is the continuous production, in a controlled environment, of plant biomass from photosynthetic phytoreplicators.

Read also – [Funding News] Comun Raises $21.5 Million in Series A Funding

This is followed by the extraction, fractionation and purification steps that make it possible to isolate the specific molecules essential to many sought-after products in the pharmaceutical, cosmetic and food industries.

“The Aplantex team is proud of the support from Frederick Perrault, the Circular Innovation Fund, Cycle Momentum, and Investissement Québec to scale our green biotechnology. We are accelerating our production and commercialization efforts, consolidating our position in key industries. The valuable lessons from our participation in Cycle Momentum’s 2023 Climate Innovation Super Cohort and the 2023 CIF Accelerator Program have also contributed to our success.” Patrick Charest, B. Sc., Eng., CEO of Aplantex.

Aplantex’s proprietary technology builds on the latest scientific developments in the “omics” field, with a practical, low cost and easily scalable industrial approach. By mastering, redirecting and optimizing the metabolism of our photosynthetic phytoreplicators, we are building the industrial capacity to supply the phytochemical ingredients’ market with any valuable product required by our clients.

“The brainpower, focus, energy, open mindedness, and listening skills of the Aplantex team are impressive. By helping current buyers of high-value plant-based molecules circumvent growing supply chain disruptions and significantly reduce their environmental footprints, the Aplantex solution is a real game-changer.” Frederick Perrault, strategic advisor, lead investor and Board member.

“Supporting the growth of our local start-ups is critical to bringing new innovative initiatives to market. With its green biotechnology process, Aplantex delivers a solution that will help key industries increase productivity in an environmentally responsible way. ” Pierre Fitzgibbon, Minister of Economy, Innovation and Energy, Minister Responsible for Regional Economic Development and Minister Responsible for the Metropolis and the Montréal Region.

About Aplantex

Aplantex has been created by a team of entrepreneurs and scientific specialists after a careful validation of the technical concept first formulated in 2019. With the support of our academic and industrial partners, we are now aiming at producing a large catalog of high value plant-based active ingredients to be used within the pharmaceutical, cosmetics and agri-food markets.

- Advertisement -
RELATED ARTICLES
- Advertisment -

Most Popular